Intelligent Bio Solutions Inc., a medical technology company, announced a 1-for-10 reverse split of its common stock.
The reverse stock split will be effective on December 15, 2025, with trading continuing on a split-adjusted basis.
The split was approved by stockholders, with adjustments to outstanding equity-based awards and no fractional shares being issued.
Reverse Stock Split
1-for-10 reverse split of common stock with effective date on December 15, 2025.
Stockholder Approval
Approved by stockholders at the annual meeting on October 16, 2025.
Adjustments
Proportionate adjustments to equity-based awards and no issuance of fractional shares.
- The reverse stock split consolidates shares to maintain stockholder interests.
- The Company's shares will be combined to reduce outstanding shares and streamline equity.
- Proportionate adjustments ensure fair treatment of equity-based awards and rights.
The reverse stock split marks a strategic move by Intelligent Bio Solutions to enhance its market positioning and equity structure.